Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Immuno-Oncology market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 14.4% during the forecast period.
This report presents the market size and development trends by detailing the Immuno-Oncology market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Immuno-Oncology market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Immuno-Oncology industry and will help you to build a panoramic view of the industrial development.
Immuno-Oncology Market, By Type:
Type 1
Type 2
Type 3
Immuno-Oncology Market, By Application:
End-Users 1
End-Users 2
End-Users 3
Some of the leading players are as follows:
Argos Therapeutics
Amgen
Biovest International
Advaxis
AbGenomics Corporation
Biosidus
Baxter International
3M Pharmaceuticals
ANI Pharmaceuticals
AVAX Technologies
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Immuno-Oncology Market: Technology Type Analysis
-
4.1 Immuno-Oncology Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Immuno-Oncology Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Type 1
4.3.2 Type 2
4.3.3 Type 3
5 Immuno-Oncology Market: Product Analysis
-
5.1 Immuno-Oncology Product Market Share Analysis, 2018 & 2026
-
5.2 Immuno-Oncology Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Immuno-Oncology Market: Application Analysis
-
6.1 Immuno-Oncology Application Market Share Analysis, 2018 & 2026
-
6.2 Immuno-Oncology Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 End-User 1
6.3.2 End-User 1
6.3.3 End-User 3
7 Immuno-Oncology Market: Regional Analysis
-
7.1 Immuno-Oncology Regional Market Share Analysis, 2018 & 2026
-
7.2 Immuno-Oncology Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Argos Therapeutics
9.1.1 Argos Therapeutics Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Amgen
9.2.1 Amgen Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Biovest International
9.3.1 Biovest International Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Advaxis
9.4.1 Advaxis Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 AbGenomics Corporation
9.5.1 AbGenomics Corporation Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Biosidus
9.6.1 Biosidus Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Baxter International
9.7.1 Baxter International Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 3M Pharmaceuticals
9.8.1 3M Pharmaceuticals Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 ANI Pharmaceuticals
9.9.1 ANI Pharmaceuticals Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 AVAX Technologies
9.10.1 AVAX Technologies Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 72 Figures and 137 Tables)
Figure Type 1 Immuno-Oncology market, 2015 - 2026 (USD Million)
Figure Type 2 Immuno-Oncology market, 2015 - 2026 (USD Million)
Figure Type 3 Immuno-Oncology market, 2015 - 2026 (USD Million)
Figure End-Users 1 market, 2015 - 2026 (USD Million)
Figure End-Users 2 market, 2015 - 2026 (USD Million)
Figure End-Users 3 market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Immuno-Oncology market, by country, 2015 - 2026 (USD Million)
-
Table North America Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table North America Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table North America Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Canada Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Canada Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Europe Immuno-Oncology market, by country, 2015 - 2026 (USD Million)
-
Table Europe Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Europe Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Europe Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Germany Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Germany Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table France Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table France Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Italy Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Italy Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Spain Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Spain Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immuno-Oncology market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table China Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table China Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Japan Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Japan Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table India Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table India Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Immuno-Oncology market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table MEA Immuno-Oncology market, by country, 2015 - 2026 (USD Million)
-
Table MEA Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table MEA Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table MEA Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Immuno-Oncology market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Immuno-Oncology market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Immuno-Oncology market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Argos Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amgen Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biovest International Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Advaxis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AbGenomics Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biosidus Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Baxter International Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table 3M Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ANI Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AVAX Technologies Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
